← Evidence map

ArticleCancer cell international2022

Etomoxir, a carnitine palmitoyltransferase 1 inhibitor, combined with temozolomide reduces stemness and invasiveness in patient-derived glioblastoma tumorspheres.

Jin-Kyoung Shim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

40 papers cite it

2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 36221088